155 related articles for article (PubMed ID: 24453273)
1. XRCC3 polymorphisms are associated with the risk of developing radiation-induced late xerostomia in nasopharyngeal carcinoma patients treated with intensity modulation radiated therapy.
Zou Y; Song T; Yu W; Zhao R; Wang Y; Xie R; Chen T; Wu B; Wu S
Jpn J Clin Oncol; 2014 Mar; 44(3):241-8. PubMed ID: 24453273
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
[TBL] [Abstract][Full Text] [Related]
4. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
5. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
Yuan X; Liao Z; Liu Z; Wang LE; Tucker SL; Mao L; Wang XS; Martel M; Komaki R; Cox JD; Milas L; Wei Q
J Clin Oncol; 2009 Jul; 27(20):3370-8. PubMed ID: 19380441
[TBL] [Abstract][Full Text] [Related]
7. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
8. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
Chen J; Liu P; Wang Q; Wu L; Zhang X
Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
[TBL] [Abstract][Full Text] [Related]
9. Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer.
Marucci L; Marzi S; Sperduti I; Giovinazzo G; Pinnarò P; Benassi M; Strigari L
Head Neck; 2012 Mar; 34(3):328-35. PubMed ID: 21400632
[TBL] [Abstract][Full Text] [Related]
10. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
[TBL] [Abstract][Full Text] [Related]
11. Trismus, xerostomia and nutrition status in nasopharyngeal carcinoma survivors treated with radiation.
Chen YJ; Chen SC; Wang CP; Fang YY; Lee YH; Lou PJ; Ko JY; Chiang CC; Lai YH
Eur J Cancer Care (Engl); 2016 May; 25(3):440-8. PubMed ID: 25495287
[TBL] [Abstract][Full Text] [Related]
12. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.
Guerra JL; Gomez D; Wei Q; Liu Z; Wang LE; Yuan X; Zhuang Y; Komaki R; Liao Z
Radiother Oncol; 2012 Dec; 105(3):299-304. PubMed ID: 23022171
[TBL] [Abstract][Full Text] [Related]
13. Intensity modulated radiation therapy in nasopharyngeal carcinoma.
Haberer-Guillerm S; Touboul E; Huguet F
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):147-51. PubMed ID: 25553970
[TBL] [Abstract][Full Text] [Related]
14. Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
Lee TF; Liou MH; Ting HM; Chang L; Lee HY; Wan Leung S; Huang CJ; Chao PJ
Sci Rep; 2015 Aug; 5():13165. PubMed ID: 26289304
[TBL] [Abstract][Full Text] [Related]
15. The effects of functional polymorphisms in the TGFβ1 gene on nasopharyngeal carcinoma susceptibility.
Hu S; Zhou G; Zhang L; Jiang H; Xiao M
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):579-84. PubMed ID: 22282866
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
[TBL] [Abstract][Full Text] [Related]
17. No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study.
Khaali W; Moumad K; Ben Driss EK; Benider A; Ben Ayoub W; Hamdi-Cherif M; Boualga K; Hassen E; Corbex M; Khyatti M
BMC Med Genet; 2016 Oct; 17(1):72. PubMed ID: 27733130
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD
Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029
[TBL] [Abstract][Full Text] [Related]
20. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
